TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 91 filers reported holding TRINITY BIOTECH PLC in Q2 2015. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,783,000 | +18.9% | 134,894 | +2.0% | 0.12% | +24.7% |
| Q2 2016 | $1,500,000 | -39.3% | 132,268 | -37.6% | 0.09% | -39.2% |
| Q1 2016 | $2,472,000 | +13.0% | 212,007 | +14.0% | 0.15% | +21.4% |
| Q4 2015 | $2,188,000 | +30.5% | 186,047 | +27.0% | 0.13% | +34.0% |
| Q3 2015 | $1,676,000 | -36.9% | 146,525 | -0.3% | 0.09% | -31.4% |
| Q2 2015 | $2,654,000 | -4.9% | 146,982 | +1.4% | 0.14% | -12.7% |
| Q1 2015 | $2,791,000 | +8.6% | 145,008 | -1.2% | 0.16% | +10.6% |
| Q4 2014 | $2,569,000 | +19.5% | 146,711 | +24.7% | 0.14% | +16.4% |
| Q3 2014 | $2,150,000 | -6.8% | 117,661 | +17.5% | 0.12% | +0.8% |
| Q2 2014 | $2,306,000 | -5.5% | 100,131 | -0.5% | 0.12% | -14.2% |
| Q1 2014 | $2,439,000 | -8.0% | 100,667 | -4.5% | 0.14% | -8.4% |
| Q4 2013 | $2,650,000 | -9.6% | 105,424 | -21.7% | 0.15% | -23.4% |
| Q3 2013 | $2,930,000 | +19.8% | 134,671 | -7.2% | 0.20% | +6.9% |
| Q2 2013 | $2,445,000 | – | 145,101 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospect Capital Advisors, LLC | 336,550 | $3,924,000 | 4.65% |
| ACK Asset Management | 979,600 | $11,422,000 | 4.49% |
| Balter Liquid Alternatives, LLC | 161,284 | $1,881,000 | 4.33% |
| GOLDMAN CAPITAL MANAGEMENT INC | 396,690 | $4,625,000 | 3.50% |
| Paradice Investment Management LLC | 1,435,724 | $16,741,000 | 2.23% |
| Adirondack Research & Management Inc. | 415,353 | $4,843,000 | 1.76% |
| Lapides Asset Management, LLC | 705,100 | $8,221,000 | 1.47% |
| Park West Asset Management LLC | 900,000 | $10,494,000 | 0.99% |
| Benchmark Capital Advisors | 83,541 | $974,000 | 0.86% |
| HEARTLAND ADVISORS INC | 1,290,010 | $15,042,000 | 0.79% |